Business Description
Veritas In Silico Inc
ISIN : JP3155340007
Description
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.98 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 108.25 | |||||
| Beneish M-Score | -2.04 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.48 | |||||
| 9-Day RSI | 65.89 | |||||
| 14-Day RSI | 61.47 | |||||
| 6-1 Month Momentum % | -46.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 63.66 | |||||
| Quick Ratio | 63.22 | |||||
| Cash Ratio | 60.54 | |||||
| Days Sales Outstanding | 88.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -34.89 | |||||
| Net Margin % | -47.11 | |||||
| FCF Margin % | 33.83 | |||||
| ROE % | -4.72 | |||||
| ROA % | -4.56 | |||||
| ROIC % | -78.26 | |||||
| ROC (Joel Greenblatt) % | -159.93 | |||||
| ROCE % | -3.5 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 36.54 | |||||
| PB Ratio | 3.13 | |||||
| Price-to-Tangible-Book | 3.14 | |||||
| Price-to-Free-Cash-Flow | 93.9 | |||||
| Price-to-Operating-Cash-Flow | 91.12 | |||||
| EV-to-EBIT | -74.54 | |||||
| EV-to-EBITDA | -74.54 | |||||
| EV-to-Revenue | 26.01 | |||||
| EV-to-FCF | 65.98 | |||||
| Price-to-Net-Current-Asset-Value | 3.16 | |||||
| Price-to-Net-Cash | 3.33 | |||||
| Earnings Yield (Greenblatt) % | -1.34 | |||||
| FCF Yield % | 0.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Veritas In Silico Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 197.103 | ||
| EPS (TTM) (円) | -15.372 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 61.47 | ||
| 14-Day ATR (円) | 80.456739 | ||
| 20-Day SMA (円) | 1004.15 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (円) | 637 - 3475 | ||
| Shares Outstanding (Mil) | 6.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Veritas In Silico Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Veritas In Silico Inc Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Veritas In Silico Inc Frequently Asked Questions
What is Veritas In Silico Inc(TSE:130A)'s stock price today?
The current price of TSE:130A is 円1138.00. The 52 week high of TSE:130A is 円3475.00 and 52 week low is 円637.00.
When is next earnings date of Veritas In Silico Inc(TSE:130A)?
The next earnings date of Veritas In Silico Inc(TSE:130A) is .
Does Veritas In Silico Inc(TSE:130A) pay dividends? If so, how much?
Veritas In Silico Inc(TSE:130A) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers